From the Editor
The Long Wait
Brevity is the name of the game in today’s world of “two-minute reads” and 280-character tweets, a world in which biomedical breakthroughs are trumpeted in a barrage of sound bites—“Scientists find cure for X,” or “Long-held treatment for Y proven ineffective—giving us little opportunity to mull, ponder and stew.
With Hopkins Medicine, we’re grateful to run counter to this trend. We remain committed to in-depth treatment of important stories—and to providing historical context whenever possible. After all, today’s headline-grabbing game changers almost always are built on the work of earlier innovations. We think it’s important not to lose sight of that.
This through-line is perhaps easiest to discern in our yearlong “Shoulders of Giants” series, in which we trace contemporary breakthroughs back to seminal contributions made by Johns Hopkins “greats” in the school’s early years. But you’ll also find this context building in other feature stories. In “Homing In on Diversity,” for example, writer Mat Edelson carefully reports that recent progress in minority faculty hiring had important precedent in work done by some administrators and faculty members of color dating back several decades. And our “Mighty Mouse” lab science story on the gene-editing tool CRISPR features a stunning medical illustration by Jennifer Fairman. In it, she shows how CRISPR improves upon embryonic stem transfer, the technique widely used until just a few years ago.
Taking the long view requires an investment in time and thought—on our end, and yours as well. We think it’s an investment worth making and hope you do, too.